StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) stock

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$1.06+0.02 (+1.92%)

Close on Nov 17, 2026Market cap $116.17KP/E –Yield –

XORTX Therapeutics total assets

Total assets on the balance sheet at the end of each period.

XORTX Therapeutics's total assets was C$22.04M at Dec 31, 2021. For fiscal 2021 it was C$22.04M, up 862.1% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2021Dec 31, 2021C$22.04M+862.1%
FY2020Dec 31, 2020C$2.29M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021C$22.04M–
Q4 FY2020Dec 31, 2020C$2.29M–

More XORTX Therapeutics figures

See a number that looks wrong?